Neuphoria Therapeutics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NEUP research report →
Range $7 – $7
Price Chart
About the company
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders.
- CEO
- Spyridon Papapetropoulos
- IPO
- 2021
- Employees
- 1
- HQ
- Burlington, MA, US
Get TickerSpark's AI analysis on NEUP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $18.65M
- P/E
- -0.47
- PEG
- -0.01
- P/S
- 15.88
- P/B
- 0.76
- EV/EBITDA
- 0.09
- Div Yield
- 0.00%
- Gross Margin
- 43.54%
- Op Margin
- -1187.73%
- Net Margin
- -1578.40%
- ROE
- -77.03%
- ROIC
- -49.41%
Latest fiscal year · YoY change
- Revenue
- $1.17M-92.5%
- Gross Profit
- $511.21K-96.6%
- Op Income
- $-9,810,480
- Net Income
- $-13,451,931-3539.3%
- EPS
- $-3.06-1230.4%
- OCF Growth
- -16095.4%
- FCF Growth
- -16095.4%
- 52W High
- $19.56
- 52W Low
- $3.19
- 50D MA
- $3.78
- 200D MA
- $4.22
- Beta
- 0.75
- RSI (14)
- 24
- Avg Volume
- 164.99K
No earnings-call transcripts are available for NEUP yet.
- Free Float
- 77.5%
- Shares Outstanding
- 5.40M
- Float Shares
- 4.19M
of shares held by institutions
19 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Lynx1 Capital Management LP | 875.33K | 0 |
| Advisorshares Investments LLC | 252.91K | ▲ 97.54K |
| Vanguard Capital Management LLC | 173.49K | ▲ 74.97K |
| Shay Capital LLC | 155.82K | ▲ 4.81K |
| Balyasny Asset Management L.P. | 142.23K | ▲ 45 |
| Citadel Advisors LLC | 72.56K | ▲ 53.23K |
| Geode Capital Management, LLC | 49.52K | ▼ 2.49K |
| Ikarian Capital, LLC | 47.44K | 0 |
| Vanguard Fiduciary Trust Co | 33.81K | ▲ 217 |
| Adar1 Capital Management, LLC | 30.00K | 0 |
| Fny Investment Advisers, LLC | 26.50K | 0 |
| Renaissance Technologies LLC | 25.50K | ▲ 25.50K |
Held by 21 ETFs
Biggest fund positions in NEUP by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 20, 26 | Wilson David Ian | other | 8,537 |
| Jan 20, 26 | Davies Peter Miles Winston | other | 8,537 |
| Jan 20, 26 | Fisher Alan | other | 17,073 |
| Jan 20, 26 | Ryan Jane | other | 8,537 |
| Oct 21, 25 | Lynx1 Capital Management LP | buy | 639,110 |
| Oct 21, 25 | Lynx1 Capital Management LP | other | 0 |
| Aug 27, 25 | Papapetropoulos Spyros | other | 34,559 |
| Apr 16, 25 | Papapetropoulos Spyros | other | 27,000 |
| Apr 16, 25 | Papapetropoulos Spyros | other | 270,000 |
| Apr 16, 25 | Davies Peter Miles Winston | other | 6,783 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NEUP coverage
Recent articles, reports, and earnings notes.
No research on NEUP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NEUP report →Are CBZ, SAFT, NEUP, TCBK Obtaining Fair Deals for their Shareholders?
prnewswire.com · Aug 4
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—NRIM, NEUP, SAFT, and RMAX
globenewswire.com · Jul 30
Are CBZ, SAFT, NEUP Obtaining Fair Deals for their Shareholders?
prnewswire.com · Jul 29
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—PBCO, NEUP, SAFT, and PFLC
globenewswire.com · Jul 28
NEUP Stock Alert: Halper Sadeh LLC is Investigating Whether Neuphoria Therapeutics Inc. is Obtaining a Fair Price for its Shareholders
gurufocus.com · Jul 24
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Neuphoria Therapeutics, Inc. (NASDAQ: NEUP)
gurufocus.com · Jul 24
NEUP Stock Alert: Halper Sadeh LLC is Investigating Whether Neuphoria Therapeutics Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com · Jul 24
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Neuphoria Therapeutics, Inc. (NASDAQ: NEUP)
prnewswire.com · Jul 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.